We are live on ! Find out more
NEXI

NexImmune, Inc. Common Stock
NEXI

Delisted

NEXI was delisted on the 11th of July, 2024.

Back to rankings

44 hedge funds and large institutions have $13.4M invested in NexImmune, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less funds holding

Funds holding: 52 → 44 (-8)

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17

62% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 13

67% less capital invested

Capital invested by funds: $40.1M → $13.4M (-$26.7M)

Holders
44
Holders Change
-8
Holders Change %
-15.38%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
5
Reduced
13
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KHCM
Kettle Hill Capital Management
New York
+$675K
2
ECG
EPIQ Capital Group
California
+$495K
3
Millennium Management
Millennium Management
New York
+$449K
4
E
Ergoteles
New York
+$213K
5
Citadel Advisors
Citadel Advisors
Florida
+$105K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.93M
2
JP Morgan Chase
JP Morgan Chase
New York
-$1.07M
3
BBA
Baker Bros. Advisors
New York
-$679K
4
KCM
Kingdon Capital Management
New York
-$497K
5
State Street
State Street
Massachusetts
-$473K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACH
1
ArrowMark Colorado Holdings
Colorado
$2.13M – – –
AG
2
Artal Group
Luxembourg
$1.93M – – –
SPC
3
Slate Path Capital
New York
$1.49M – – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$1.29M – – –
AO
5
Allen Operations
New York
$1.02M – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
$845K -$1.36K -22 -0.1%
Vanguard Group
7
Vanguard Group
Pennsylvania
$720K +$90.8K +1,467 +9%
BM
8
Bridger Management
New York
$644K – – –
ECG
9
EPIQ Capital Group
California
$629K +$495K +8,000 +105%
KHCM
10
Kettle Hill Capital Management
New York
$439K +$675K +10,898 New
Millennium Management
11
Millennium Management
New York
$292K +$449K +7,252 New
MCM
12
M28 Capital Management
Connecticut
$215K – – –
BBHC
13
Brown Brothers Harriman & Co
New York
$198K – – –
PNC Financial Services Group
14
PNC Financial Services Group
Pennsylvania
$180K – – –
6CM
15
683 Capital Management
New York
$162K – – –
First Manhattan
16
First Manhattan
New York
$146K – – –
E
17
Ergoteles
New York
$139K +$213K +3,448 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$101K -$304K -4,915 -66%
CG
19
Caprock Group
Idaho
$91K – – –
BCM
20
Bridgeway Capital Management
Texas
$81K – – –
BlackRock
21
BlackRock
New York
$72K -$1.93M -31,201 -95%
Citadel Advisors
22
Citadel Advisors
Florida
$68K +$105K +1,693 New
RJA
23
Raymond James & Associates
Florida
$49K +$24.8K +400 +48%
Goldman Sachs
24
Goldman Sachs
New York
$47K +$72K +1,163 New
Rockefeller Capital Management
25
Rockefeller Capital Management
New York
$44K – – –
1
2 3

NEXI Hedge Fund Activity: Q2 2022 in Review

44 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q2 2022, worth a combined $13.4M — down 67% from $40.1M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of NEXI and 11 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 5 added.

The largest buyer was Kettle Hill Capital Management, opening a new position worth an estimated $675K. The largest seller was BlackRock, cutting an estimated $1.93M.

  • 44 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q2 2022, down from 52 in Q1 2022.
  • Funds reported $13.4M of NexImmune, Inc. Common Stock stock for Q2 2022, down 67% quarter-over-quarter.
  • 11 funds opened new NexImmune, Inc. Common Stock positions in Q2 2022 and 17 closed out, a net change of -6 holders.
  • The largest NexImmune, Inc. Common Stock buyer in Q2 2022 was Kettle Hill Capital Management, an estimated $675K added.
  • The largest NexImmune, Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $1.93M sold.

Based on aggregated 13F filings for Q2 2022.